Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett Michael Frampton, Alex Fichtenholtz, Geoff A. Otto et al. · Nature Biotechnology · 2013
Cited by 2,154 works. doi:10.1038/nbt.2696
Authors
- Garrett Michael Frampton
- Alex Fichtenholtz
- Geoff A. Otto
- Sean R. Downing
- Jie He
- Michael Schnall-Levin
- Jared R. White
- Eric M. Sanford
- Peter An
- James Sun
- Frank Juhn
- Kristina W. Brennan
- Kiel Iwanik
- Ashley Maillet
- Jamie K. Buell
- Emily T. White
- Mandy Zhao
- Sohail Balasubramanian
- Selmira Terzic
References
- The Sequence Alignment/Map format and SAMtools
- Fast and accurate short read alignment with Burrows–Wheeler transform
- dbSNP: the NCBI database of genetic variation
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- Comprehensive genomic characterization of squamous cell lung cancers
- The landscape of somatic copy-number alteration across human cancers
- Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
- International network of cancer genome projects